nicotine 2 MG Chewing Gum [Nicorette]
- RxCUI
- 209326
- RxNorm name
- nicotine 2 MG Chewing Gum [Nicorette]
- Display name
- NICORETTE (Chewable)
- Full name
- nicotine 2 MG Chewing Gum [Nicorette]
- Term type
- SBD
- Status
- Active
- Strength
- 2 mg
- Dose form
- Gum
- Route
- Chewable
- Updated
- 2026-11-08 10:19:42
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| nicotine polacrilex | 2 MG / 1 EACH | nicotine | nicotine |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Chewing Gum | 402499 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| nicotine | 7407 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Nicorette 2 MG Chewing Gum | 1 | NAMES |
| RxNorm Name | nicotine 2 MG Chewing Gum [Nicorette] | 1 | NAMES |
| RxNorm Synonym | 2 | NAMES | |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 2 | CODES | |
| RxCUI | 209326 | 1 | CODES |
| MMSL_CODE | BD3787 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0135-0157-07 | 0135-0157 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0157-10 | 0135-0157 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0157-11 | 0135-0157 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0229-05 | 0135-0229 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0241-02 | 0135-0241 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0241-05 | 0135-0241 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0241-06 | 0135-0241 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0241-08 | 0135-0241 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0241-17 | 0135-0241 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0241-18 | 0135-0241 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0241-19 | 0135-0241 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0466-01 | 0135-0466 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0466-02 | 0135-0466 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0466-03 | 0135-0466 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0466-05 | 0135-0466 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0466-07 | 0135-0466 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0466-08 | 0135-0466 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0474-01 | 0135-0474 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0474-02 | 0135-0474 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0474-05 | 0135-0474 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0474-08 | 0135-0474 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0474-17 | 0135-0474 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0474-18 | 0135-0474 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0474-19 | 0135-0474 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0474-20 | 0135-0474 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0532-02 | 0135-0532 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0532-03 | 0135-0532 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0532-12 | 0135-0532 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0532-13 | 0135-0532 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
| 0135-0532-14 | 0135-0532 | Nicorette nicotine polacrilex | Haleon US Holdings LLC | NDA018612 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 673fd19f-69b3-4f73-b9b4-18b5f4cbf69c | Nicorette 2 MG Chewing Gum [PSN] · nicotine 2 MG Chewing Gum [Nicorette] [SBD] · Nicorette 2 MG (as nicotine polacrilex 22.2 MG) Chewing Gum [SY] · Nicorette 2 MG Chewing Gum [SY] | 4 | 27 | Drug Facts | 20240813 |
| a0206139-59c6-44c3-963c-8cb5f2d69075 | Nicorette 2 MG Chewing Gum [PSN] · nicotine 2 MG Chewing Gum [Nicorette] [SBD] · Nicorette 2 MG (as nicotine polacrilex 22.2 MG) Chewing Gum [SY] · Nicorette 2 MG Chewing Gum [SY] | 4 | 20 | Drug Facts | 20240729 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 673fd19f-69b3-4f73-b9b4-18b5f4cbf69c | Drug Facts | Haleon US Holdings LLC | 20240813 |
| a0206139-59c6-44c3-963c-8cb5f2d69075 | Drug Facts | Haleon US Holdings LLC | 20240729 |
| aa55c691-e610-4527-a246-1a14f67ba81a | National Council for Prescription Drug Programs | 20130213 | |
| 81f07711-d090-4210-a36a-faf7e69cce72 | National Council for Prescription Drug Programs | 20130213 | |
| 4575fe06-0df7-480f-b888-67f45c9a939b | National Council for Prescription Drug Programs | 20120724 | |
| d443bfb1-cb27-459c-97e6-7a06ba280844 | National Council for Prescription Drug Programs | 20120724 | |
| b81b5537-8010-4f37-8c8c-9aab803f7e3d | National Council for Prescription Drug Programs | 20120724 | |
| 836511c2-0dd1-40b3-b2c3-a79af8a9055a | National Council for Prescription Drug Programs | 20120724 | |
| 65a0a597-41cd-4666-841a-66c49705e619 | National Council for Prescription Drug Programs | 20120724 | |
| 0434ed76-7d07-4be9-81f2-42af7709a718 | National Council for Prescription Drug Programs | 20120724 | |
| 2111fe2e-defe-4d1d-80d4-c240edcb3376 | National Council for Prescription Drug Programs | 20120724 | |
| 2044d89f-3055-4242-8757-172ca504e4ef | National Council for Prescription Drug Programs | 20120724 | |
| 1fd63694-cabc-47a0-af5b-711abf355355 | National Council for Prescription Drug Programs | 20120724 | |
| 1c2742b1-23e5-4f58-aa0d-f4c0dfc34e64 | National Council for Prescription Drug Programs | 20120724 | |
| 0991b77e-fc04-456b-ab21-78c06fda96e5 | National Council for Prescription Drug Programs | 20120724 | |
| 06f52938-8d2e-4981-b92c-f538f94f2011 | National Council for Prescription Drug Programs | 20120724 | |
| 05397702-6ffe-449a-b0af-4e4d7c2fe5e6 | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N07BA | Drugs used in nicotine dependence | ATC1-4 | nicotine | |
| FDASPL | D009538 | Nicotine | CHEM | has_chemical_structure | nicotine |
| FDASPL | N0000175706 | Cholinergic Nicotinic Agonist | EPC | has_epc | nicotine |
| MEDRT | D009538 | Nicotine | CHEM | has_ingredient | nicotine |
| MEDRT | D000787 | Angina Pectoris | DISEASE | ci_with | nicotine |
| MEDRT | D001145 | Arrhythmias, Cardiac | DISEASE | ci_with | nicotine |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | nicotine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | nicotine |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | ci_with | nicotine |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | nicotine |
| MEDRT | D013375 | Substance Withdrawal Syndrome | DISEASE | may_prevent | nicotine |
| MEDRT | D013705 | Temporomandibular Joint Disorders | DISEASE | ci_with | nicotine |
| MEDRT | D014029 | Tobacco Use Disorder | DISEASE | may_treat | nicotine |
| MEDRT | N0000000143 | Cholinergic Nicotinic Agonists | MOA | has_moa | nicotine |
| MEDRT | N0000009178 | Increased Central Nervous System Acetylcholine Activity | PE | has_pe | nicotine |
| MEDRT | N0000009393 | Increased Medullary Respiratory Drive | PE | has_pe | nicotine |
| MEDRT | N0000009427 | Increased Muscular System Acetylcholine Activity | PE | has_pe | nicotine |
| MEDRT | N0000009494 | Increased Peripheral Nervous System Acetylcholine Activity | PE | has_pe | nicotine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 2 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA018612 |
| NAMES | Prescribable Synonym | Nicorette 2 MG Chewing Gum |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |